- Home
- CPD Activities
- Impact of ascorbic acid in reducing the incidence of vancomycin associated nephrotoxicity in critically ill patients: A preliminary randomized controlled trial
Impact of ascorbic acid in reducing the incidence of vancomycin associated nephrotoxicity in critically ill patients: A preliminary randomized controlled trial
| Name | World Continuing Education Alliance |
|---|
| Activity Title | Impact of ascorbic acid in reducing the incidence of vancomycin associated nephrotoxicity in critically ill patients: A preliminary randomized controlled trial |
|---|
| Details | Impact of ascorbic acid in reducing the incidence of vancomycin associated nephrotoxicity in critically ill patients: A preliminary randomized controlled trial |
|---|
| Competence | General Medicine |
|---|
| Start Date | <span class="not-set">(not set)</span> |
|---|
| End Date | <span class="not-set">(not set)</span> |
|---|
| Event Time | 12:15 PM |
|---|
| Location | World Continuing Education Alliance eLearning System |
|---|
| Cost (UGX) | 0 |
|---|
| CPD Points | 1 |
|---|